[1] LELLIS D,LLOYD R,HEITZ P U,et al.WHO classification of tumours.Pathology and genetics of tumours of endocrine organs[M].Lyon:IARC Press,2004:1-5766.
[2] HAUGEN B R,ALEXANDER E K,BIBLE K C,et al.2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:The American thyroid association guidelines task force on thyroid nodules and differentiatedthyroid cancer[J].Thyroid,2016,6(1):1-133.
[3] LLOYD R V,BUEHLER D,KHANAFSHAR E.Papillary thyroid carcinoma variants[J].Head Neck Pathol,2011,5(1):51-56.
[4] JEMAL A,SIEGEL R,WARD E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
[5] NIKIFOROV Y E,SEETHALA R R,TALLINI G,et al.Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma a paradigm shift to reduce overtreatment of indolent tumors[J].JAMA Oncol,2016,2(8):1023-1029.
[6] BONGIOVANNI M,SPITALE A,FAQUIN W C,et al.The Bethesda system for reporting thyroid cytopathology:a meta-analysis[J].Acta Cytol,2012,56(4):333-339.
[7] CRILE G J,HAZARD J B.Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid[J].Ann Surg,1953,138(1):33-38.
[8] NIKIFOROV Y E,SEETHALA R R,TALLINI G,et al.Nomenclature revisionfor encapsulated follicular variant of papillary thyroid carcinoma.A paradigm shift to reduce overtreatment of indolent tumors[J].JAMA Oncol,2016,2(8):1023-1029.
[9] GANLY I,WANG L,TUTTLE R M,et al.Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors:further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant[J].Hum Pathol,2015,46(5):657-664.
[10] HOWITT B E,JIA Y,SHOLL L M,et al.Molecular alterations in partially-encapsulated/well-circumscribed follicular variant of papillary thyroid carcinoma[J].Thyroid,2013,23(10):1256-1262.
[11] VIVERO M,KRAFT S,BARLETTA J A.Risk stratification of follicular variant of papillary thyroid carcinoma[J].Thyroid,2013,23(3):273-279.
[12] RIVERA M,RICARTE-FILHO J,KNAUF J,et al.Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns[J].Mod Pathol,2010,23(9):1191-1200.
[13] HOWITT B E,PAULSON V A,BARLETTA J A.Absence of BRAF V600E in non-infiltrative,non-invasive follicular variant of papillary thyroid carcinoma[J].Histopathology,2015,67(4):579-582.
[14] THOMPSON L D.Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma:a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment[J].Mod Pathol,2016,29(7):698-707.
[15] SHIN J H.Ultrasonographic imaging of papillary thyroid carcinoma variants[J].Ultrasonography,2017,36(2):103-110.
[16] BONGIOVANNI M,SPITALE A,FAQUIN W C,et al.The bethesda system for reporting thyroid cytopathology:a meta-analysis[J].Acta Cytol,2012,56(4):333-339.
[17] HAWK W A,HAZARD J B.The many appearances of papillary carcinoma of the thyroid[J].Cleve Clin Q,1976,43(4):207-215.
[18] WANG X,CHENG W,LIU C,et al.Tall cell variant of papillary thyroid carcinoma:current evidence on clinicopathologic features and molecular biology[J].Oncotarget,2016,7(26):40792-40799.
[19] 成殷,崔全才.甲状腺乳头状癌高细胞亚型的临床病理学研究进展[J].诊断病理学杂志,2015,22(3):181-184.
[20] LASTRA R R,LIVOLSI V A,BALOCH Z W.Aggressive variants of follicular cell-derived thyroid carcinomas:a cytopathologist's perspective[J].Cancer Cytopathol,2014,122(7):484-503.
[21] Cancer Genome Atlas Research Network.Integrated Genomic Characterization of Papillary Thyroid Carcinoma[J].Cell,2014,159(3):676-690.
[22] DAS D K,MALLIK M K,SHARMA P,et al.Papillary thyroid carcinoma and its variants in fine needle aspiration smears[J].Acta Cytol,2004,48(3):325-336.
[23] HUI P K,CHAN J K C,CHEUNG P S,et al.Columnar cell carcinoma of the thyroid.Fine needle aspiration findings in a case[J].Acta Cytol,1990,34(3):355-358.
[24] PÉREZ F,LLOBET M,GARIJO G,et al.Fine-needle aspiration cytology of columnar-cell carcinoma of the thyroid:report of two cases with cytohistologic correlation[J].Diagn Cytopathol,1998,18(5):352-356.
[25] JAYARAM G.Cytology of columnar-cell variant of papillary thyroid carcinoma[J].Diagn Cytopathol,2000,22(4):227-229.
[26] VERMA R,PAUL P.Columnar cell variant of papillary thyroid carcinoma:a diagnostic dilemma in fine-needle aspiration cytology[J].Diagn Cytopathol,2016,44(10):816-819.
[27] CHEN J H,FAQUIN W C,LLOYD R V,et al.Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma[J].Mod Pathol,2011,24(5):739-749.
[28] JOUNG J Y,KIM T H,JEONG D J,et al.Diffuse sclerosing variant of papillary thyroid carcinoma:major genetic alterations and prognostic implications[J].Histopathology,2016,69(1):45-53.
[29] MALANDRINO P,RUSSO M,REGALBUTO C,et al.The outcome of the diffuse sclerosing variant of papillary thyroid cancer:a meta-analysis[J].Thyroid,2016,26(9):1285-1292.
[30] BONGIOVANNI M,TRIPONEZ F,MCKEE T A,et al.Fine-needle aspiration of the diffuse sclerosing variant of papillary thyroid carcinoma masked by florid lymphocytic thyroiditis;a potential pitfall:a case report and review of the literature[J].Diagn Cytopathol,2009,37(9):671-675.
[31] TAKAGI N,HIROKAWA M,NOBUOKA Y,et al.Diffuse sclerosing variant of papillary thyroid carcinoma:a study of fine needle aspiration cytology in 20 patients[J].Cytopathology,2014,25(3):199-204.
[32] APEL R L,ASA S L,LIVOLSI V A.Papillary Hürthle cell carcinoma with lymphocytic stroma:"Warthin-like tumor" of the thyroid[J].Am J Surg Pathol,1995,19(7):810-814.
[33] RENSHAW A A.Fine-needle aspirations of papillary carcinoma with oncocytic features:An expanded cytologic and histologic profile[J].Cancer Cytopathol,2011,119(4):247-253.
[34] MONTONE K T,BALOCH Z W,LIVOLSI V A.The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions:a surgical pathology and cytopathology review[J].Arch Pathol Lab Med,2008,132(8):1241-1250.
[35] AUGER M.HVrthle cells in fine-needle aspirates of the thyroid:a review of their diagnostic criteria and significance[J].Cancer Cytopathol,2014,122(4):241-249.
[36] BALOCH Z W,LIVOLSI V A.Warthin-like papillary carcinoma of the thyroid[J].Arch Pathol Lab Med,2000,124(8):1192-1195.
[37] TROVISCO V,VIEIRA D C I,SOARES P,et al.BRAF mutations are associated with some histological types of papillary thyroid carcinoma[J].J Pathol,2010,202(2):247-251.
[38] NIKIFOROV Y E,BIDDINGER P W,THOMPSON L D.Diagnostic pathology and molecular genetics of thyroid[M].Philadelphia:Lippincott Williams and Wilkins,2012:473-673.
[39] SYWAK M,PASIEKA J L,OGILVIE T.A review of thyroid cancer with intermediate differentiation[J].J Surg Oncol,2004,86(1):44-54.
[40] LIVOLSI V A,ABROSIMOV A A,BOGDANOVA T,et al.The chernobyl thyroid cancer experience:pathology[J].Clin Oncol (R Coll Radiol),2011,23(4):261-267.
[41] NIKIFOROV Y E,ROWLAND J M,BOVE K E,et al.Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children[J].Cancer Res,1997,57(9):1690-1694.
[42] LEE Y S,KIM Y,JEON S,et al.Cytologic,clinicopathologic,and molecular features of papillary thyroid carcinoma with prominent hobnail features:10 case reports and systematic literature review[J].Int J Clin Exp Pathol,2015,8(7):7988-7997.
[43] ASIOLI S,ERICKSON L A,RIGHI A,et al.Papillary thyroid carcinoma with hobnail features:histopathologic criteria to predict aggressive behavior[J].Hum Pathol,2013,44(3):320-328.
[44] UCHINO S,ISHIKAWA H,MIYAUCHI A,et al.Age-and gender-specific risk of thyroid cancer in patients with familial adenomatous polyposis[J].J Clin Endocrinol Metab,2016,101(12):4611-4617.
[45] KOO J S,JUNG W,HONG S W.Cytologic characteristics and β-catenin immunocytochemistry on smear slide of cribriform-morular variant of papillary thyroid carcinoma[J].Acta Cytol,2011,55(1):13-18.
[46] BOONYAARUNNATE T,OLSON M T,BISHOP J A,et al.Cribriform morular variant of papillary thyroid carcinoma:clinical and cytomorphological features on fine-needle aspiration[J].Acta Cytol,2013,57(2):127-133.
[47] JUNG C K,CHOI Y J,LEE K Y,et al.The cytological,clinical,and pathological features of the cribriform-morular variant of papillary thyroid carcinoma and mutation analysis of CTNNB1 and BRAF genes[J].Thyroid,2009,19(8):905-913.
[48] OH E J,LEE S,BAE J S,et al.TERT promoter mutation in an aggressive cribriform morular variant of papillary thyroid carcinoma[J].Endocr Pathol,2017,28(1):49-53.
[49] PUSZTASZERI M,AUGER M.Update on the cytologic features of papillary thyroid carcinoma variants[J].Diagn Cytopathol,2017,45(8):714-730.
[50] RICARDO V L,ROBERT Y O,GUNTERKLOPPE L,et al.World Health Organization classification of tumors.WHO classification of tumors of endocrine organs[M].Lyon:IABC,2017:1-356.
[51] 卢燕红,王圣应.甲状腺乳头状癌罕见的侵袭性变异型[J].中华内分泌外科杂志,2014,8(1):71-73.
[52] LINO-SILVA L S,DOMÍNGUEZ-MALAGÓN H R,CARO-SÁNCHEZ C H,et al.Thyroid gland papillary carcinomas with micropapillary pattern,a recently recognized poor prognostic finding:Clinicopathologic and survival analysis of 7 cases[J].Hum Pathol,2012,43(10):1596-1600.
[53] YU X M,SCHNEIDER D F,LEVERSON G,et al.Follicular variant of papillary thyroid carcinoma is a unique clinical entity:A population-based study of 10,740 cases[J].Thyroid,2013,23(10):1263-1268.
[54] MA X,XIA C,LIU H,et al.Primary thyroid spindle cell tumors:spindle cell variant of papillary thyroid carcinoma?[J].Int J Clin Exp Pathol,2015,8(10):13528-13531. |
